LON:FBT

First Trust NYSE Arca Biotechnology UCITS ETF Share Forecast, Price & News

GBX 1,375.11

+7.61 (+0.56%)

(As of 07/1/2022 02:14 PM ET)

Add

Compare

Today's Range: 1,369.53
▼
1,375.30
50-Day Range: 1,220.30
▼
1,384.60
52-Week Range: 1,220.30
▼
1,560.40

Volume: 71 shs
Average Volume: 1,602 shs
Market Capitalization: £4.06 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology UCITS ETF and its competitors with MarketBeat's FREE daily newsletter.

FBT Stock Forecast (MarketRank)

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for First Trust NYSE Arca Biotechnology UCITS ETF.

4.4 Community Rank

Outperform Votes
First Trust NYSE Arca Biotechnology UCITS ETF has received 72 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
First Trust NYSE Arca Biotechnology UCITS ETF has received 36 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
First Trust NYSE Arca Biotechnology UCITS ETF has received 66.67% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about First Trust NYSE Arca Biotechnology UCITS ETF and other stocks. Vote “Outperform” if you believe FBT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FBT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
First Trust NYSE Arca Biotechnology UCITS ETF does not currently pay a dividend.
Dividend Growth
First Trust NYSE Arca Biotechnology UCITS ETF does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, First Trust NYSE Arca Biotechnology UCITS ETF insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of First Trust NYSE Arca Biotechnology UCITS ETF is -1,250.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of First Trust NYSE Arca Biotechnology UCITS ETF is -1,250.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
First Trust NYSE Arca Biotechnology UCITS ETF has a P/B Ratio of 723.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About First Trust NYSE Arca Biotechnology UCITS ETF (LON:FBT)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.

FBT Stock News Headlines

February 24, 2022 | apnews.com

CORRECTING and REPLACING First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETF

July 6, 2020 | www.lse.co.uk

Trading/Spreadbetting board

May 1, 2019 | finance.yahoo.com

Forbidden Technologies plc: Deltatre Extends Blackbird Partnership for Production of Sports Clips and Highlights

April 23, 2019 | finance.yahoo.com

Does Forbidden Technologies plc's (LON:FBT) Past Performance Indicate A Weaker Future?

April 4, 2019 | finance.yahoo.com

Gfinity Extends Blackbird Partnership for the Delivery of esports Clips and Highlights

April 3, 2019 | finance.yahoo.com

NAB 2019: Xytech Systems and Blackbird Partner to Streamline Asset Management Process for MediaPulse Users

March 13, 2019 | www.bloomberg.com

Forbidden Technologies PLC

March 5, 2019 | finance.yahoo.com

IMG Grows and Extends Blackbird Partnership for Another Three Years

December 19, 2018 | finance.yahoo.com

TownNews Extends Blackbird Adoption with Block Communications Deployment

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Software - Application
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: LON:FBT
CUSIP: N/A
CIK: N/A
Web: www.forbidden.co.uk
Phone: +44-20-88797245
Fax: N/A
Employees: 20
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 9.42
Quick Ratio: 9.27

Sales & Book Value

Annual Sales: £870.31 thousand
Price / Sales: 4,668.75
Cash Flow: GBX 388 per share
Price / Cash Flow: 3.54
Book Value: GBX 1.90 per share
Price / Book: 723.74

Miscellaneous

Outstanding Shares: 295,486,016
Free Float: N/A
Market Cap: £4.06 billion
Optionable: Optionable
Beta: N/A

First Trust NYSE Arca Biotechnology UCITS ETF Frequently Asked Questions

How has First Trust NYSE Arca Biotechnology UCITS ETF's stock price performed in 2022?: First Trust NYSE Arca Biotechnology UCITS ETF's stock was trading at GBX 1,468.98 at the beginning of the year. Since then, FBT stock has decreased by 6.4% and is now trading at GBX 1,375.11.
View the best growth stocks for 2022 here.
Who are First Trust NYSE Arca Biotechnology UCITS ETF's key executives?: First Trust NYSE Arca Biotechnology UCITS ETF's management team includes the following people:
Mr. Ian McDonough, CEO & Director (Age 47)
Mr. Stephen B. Streater, Founder, Director of R&D and Exec. Director
Mr. Stephen James White, Chief Operating & Financial Officer and Director (Age 48)
Adrian Lambert, Marketing Director
Rachel Darcy, Sales Director
Who are some of First Trust NYSE Arca Biotechnology UCITS ETF's key competitors?: Some companies that are related to First Trust NYSE Arca Biotechnology UCITS ETF include Open Text (OTEX), AVEVA Group (AVV), The Descartes Systems Group (DSG), Nemetschek (NEM), The Sage Group (SGE), Avast (AVST), Lightspeed Commerce (LSPD), Kinaxis (KXS), Rocket Internet (RKET), Sophos Group plc (SOPH.L) (SOPH), Enghouse Systems (ENGH), RIB Software (RIB), Kainos Group (KNOS), Blue Prism Group (PRSM) and Kape Technologies (KAPE).
View all of FBT's competitors.
What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology UCITS ETF investors own include Taylor Wimpey (TW), ARK Genomic Revolution Multi-Sector ETF (ARKG), Johnson & Johnson (JNJ), Weyerhaeuser (WY), AbbVie (ABBV), ARK Innovation ETF (ARKK), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), Global X Robotics & Artificial Intelligence ETF (BOTZ) and Caterpillar (CAT).

What is First Trust NYSE Arca Biotechnology UCITS ETF's stock symbol?: First Trust NYSE Arca Biotechnology UCITS ETF trades on the London Stock Exchange (LON) under the ticker symbol "FBT."
How do I buy shares of First Trust NYSE Arca Biotechnology UCITS ETF?: Shares of FBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is First Trust NYSE Arca Biotechnology UCITS ETF's stock price today?: One share of FBT stock can currently be purchased for approximately GBX 1,375.11.
How much money does First Trust NYSE Arca Biotechnology UCITS ETF make?: First Trust NYSE Arca Biotechnology UCITS ETF (LON:FBT) has a market capitalization of £4.06 billion and generates £870.31 thousand in revenue each year.
How many employees does First Trust NYSE Arca Biotechnology UCITS ETF have?: First Trust NYSE Arca Biotechnology UCITS ETF employs 20 workers across the globe.
How can I contact First Trust NYSE Arca Biotechnology UCITS ETF?: First Trust NYSE Arca Biotechnology UCITS ETF's mailing address is Tuition House, 27-37 St. Georges Road, LONDON, SW19 4EU, United Kingdom. The official website for First Trust NYSE Arca Biotechnology UCITS ETF is www.forbidden.co.uk. The company can be reached via phone at +44-20-88797245.

This page (LON:FBT) was last updated on 7/1/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources